Human Pregnane X Receptor Activation and CYP3A4/CYP2B6 Induction by 2,3-oxidosqualene:lanosterol Cyclase Inhibition

Overview

Journal Drug Metab Dispos

Specialty Pharmacology

Date 2009 Jan 23

PMID 19158313

Citations 6

Authors

Zofia Duniec-Dmuchowski

Hai-Lin Fang

Stephen C Strom

Ewa Ellis

Melissa Runge-Morris

Thomas A Kocarek

Affiliations

Soon will be listed here.

Abstract

The effects of [4'-(6-allyl-methyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-methanone fumarate (Ro 48-8071), an inhibitor of 2,3-oxidosqualene:lanosterol cyclase (cyclase), were evaluated on CYP3A4 and CYP2B6 mRNA content in primary cultured human hepatocytes. In seven hepatocyte culture preparations, 24-h treatment with 3, 10, or 30 microM Ro 48-8071 produced median increases in CYP3A4 mRNA content that were 2.2-, 7.1-, and 8.5-fold greater than untreated control, respectively, and produced increases in CYP2B6 mRNA content that were 3.0-, 4.6-, and 3.4-fold greater than control, respectively. Increases in CYP3A4 immunoreactive protein content were also measured in Ro 48-8071-treated hepatocytes. To evaluate the effects of cyclase inhibitor treatments further, a pregnane X receptor (PXR)-responsive transactivation assay in HepG2 cells was used. Ro 48-8071, trans-N-(4-chlorobenzoyl)-N-methyl-(4-dimethylaminomethylphenyl)-cyclohexylamine (BIBX 79), and 3beta-(2-diethylaminoethoxy)androst-5-en-17-one HCl (U18666A) induced luciferase expression from a PXR-responsive reporter with EC(50)s of 0.113, 0.916, and 0.294 microM, respectively. Treatment of the HepG2 system with (E)N-ethyl-N-(6,6-dimethyl-2-hepten-4-ynyl)-3-[(3,3'-bithiophen-5-yl)methoxy]benzenemethanamine (NB-598), an inhibitor of squalene monooxygenase, at concentrations sufficient to achieve cholesterol biosynthesis inhibition significantly inhibited cyclase inhibitor-mediated, but not rifampicin-mediated, reporter induction. Direct treatment of the HepG2 system with 1 to 10 microM squalene 2,3:22,23-dioxide, but not squalene 2,3-oxide, significantly activated PXR-responsive reporter expression. Also, squalene 2,3:22,23-dioxide bound to human PXR in vitro with an IC(50) of 3.35 microM. These data indicate that cyclase inhibitors are capable of producing CYP3A4 and CYP2B6 induction in primary cultured human hepatocytes, and that an endogenous squalene metabolite is a conserved intracrine activator of PXR.

Citing Articles

Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics.

Minegishi G, Kobayashi Y, Fujikura M, Sano A, Kazuki Y, Kobayashi K Pharmacol Res Perspect. 2024; 12(3):e1197.

PMID: 38644590 PMC: 11033495. DOI: 10.1002/prp2.1197.

Negative Regulation of Human Hepatic Constitutive Androstane Receptor by Cholesterol Synthesis Inhibition: Role of Sterol Regulatory Element Binding Proteins.

Cuko L, Duniec-Dmuchowski Z, Rondini E, Pant A, Fallon J, Wilson E Drug Metab Dispos. 2021; 49(8):706-717.

PMID: 34011532 PMC: 11025015. DOI: 10.1124/dmd.120.000341.

Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes.

Rondini E, Pant A, Kocarek T J Pharmacol Exp Ther. 2015; 355(3):429-41.

PMID: 26427720 PMC: 4658488. DOI: 10.1124/jpet.115.226365.

Development of BODIPY FL vindoline as a novel and high-affinity pregnane X receptor fluorescent probe.

Lin W, Liu J, Jeffries C, Yang L, Lu Y, Lee R Bioconjug Chem. 2014; 25(9):1664-77.

PMID: 25133934 PMC: 4166032. DOI: 10.1021/bc5002856.

Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.

Chuang J, Valasek M, Lopez A, Posey K, Repa J, Turley S Biochem Pharmacol. 2014; 88(3):351-63.

PMID: 24486573 PMC: 3989900. DOI: 10.1016/j.bcp.2014.01.031.

References

Goodwin B, Gauthier K, Umetani M, Watson M, Lochansky M, Collins J . Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci U S A. 2003; 100(1):223-8. PMC: 140933. DOI: 10.1073/pnas.0237082100. View

Shenoy S, Spencer T, Mercer-Haines N, Abdolalipour M, Wurster W, Runge-Morris M . Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes. Mol Pharmacol. 2004; 65(5):1302-12. DOI: 10.1124/mol.65.5.1302. View

Mark M, Muller P, Maier R, Eisele B . Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells. J Lipid Res. 1996; 37(1):148-58. View

Furster C, Wikvall K . Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes. Biochim Biophys Acta. 1999; 1437(1):46-52. DOI: 10.1016/s0005-2760(98)00175-1. View

Shenoy S, Spencer T, Mercer-Haines N, Alipour M, Gargano M, Runge-Morris M . CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metab Dispos. 2004; 32(1):66-71. DOI: 10.1124/dmd.32.1.66. View

Xue Y, Chao E, Zuercher W, Willson T, Collins J, Redinbo M . Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism. Bioorg Med Chem. 2007; 15(5):2156-66. PMC: 1839856. DOI: 10.1016/j.bmc.2006.12.026. View

Fang H, Strom S, Ellis E, Duanmu Z, Fu J, Duniec-Dmuchowski Z . Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor. J Pharmacol Exp Ther. 2007; 323(2):586-98. DOI: 10.1124/jpet.107.124610. View

Watkins R, Wisely G, Moore L, Collins J, Lambert M, Williams S . The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 2001; 292(5525):2329-33. DOI: 10.1126/science.1060762. View

Xie W, Radominska-Pandya A, Shi Y, Simon C, Nelson M, Ong E . An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A. 2001; 98(6):3375-80. PMC: 30661. DOI: 10.1073/pnas.051014398. View

10.

Goodwin B, Moore L, Stoltz C, McKee D, Kliewer S . Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol. 2001; 60(3):427-31. View

11.

Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M . Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1):76-85. DOI: 10.1016/0003-2697(85)90442-7. View

12.

Duniec-Dmuchowski Z, Ellis E, Strom S, Kocarek T . Regulation of CYP3A4 and CYP2B6 expression by liver X receptor agonists. Biochem Pharmacol. 2007; 74(10):1535-40. PMC: 2080783. DOI: 10.1016/j.bcp.2007.07.040. View

13.

Jones S, Moore L, Shenk J, Wisely G, Hamilton G, McKee D . The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol. 2000; 14(1):27-39. DOI: 10.1210/mend.14.1.0409. View

14.

Watkins R, Maglich J, Moore L, Wisely G, Noble S, Davis-Searles P . 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry. 2003; 42(6):1430-8. DOI: 10.1021/bi0268753. View

15.

Kocarek T, Mercer-Haines N . Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. Mol Pharmacol. 2002; 62(5):1177-86. DOI: 10.1124/mol.62.5.1177. View

16.

Gnerre C, Schuster G, Roth A, Handschin C, Johansson L, Looser R . LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver. J Lipid Res. 2005; 46(8):1633-42. DOI: 10.1194/jlr.M400453-JLR200. View

17.

Jung D, Mangelsdorf D, Meyer U . Pregnane X receptor is a target of farnesoid X receptor. J Biol Chem. 2006; 281(28):19081-91. DOI: 10.1074/jbc.M600116200. View

18.

Honda A, Salen G, Matsuzaki Y, Batta A, Xu G, Leitersdorf E . Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis. J Biol Chem. 2001; 276(37):34579-85. DOI: 10.1074/jbc.M103025200. View

19.

Boogaard A, Griffioen M, Cohen L . Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity. Biochem J. 1987; 241(2):345-51. PMC: 1147567. DOI: 10.1042/bj2410345. View

20.

Janowski B, Grogan M, Jones S, Wisely G, Kliewer S, Corey E . Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci U S A. 1999; 96(1):266-71. PMC: 15128. DOI: 10.1073/pnas.96.1.266. View